Benjamin Kasenda
Basel haematologist-oncologist who co-led phase 2 trials of high-dose chemotherapy and autologous transplant in primary CNS lymphoma.
Overview
Benjamin Kasenda is a senior physician in internal medicine and haematology/oncology at Universitätsspital Basel, working within the Tumour Centre with a focus on gastrointestinal tumours and lymphoma. He has co-authored prospective phase 2 trials in the Lancet Haematology evaluating high-dose chemotherapy with autologous stem-cell transplantation for primary CNS lymphoma, including in older patients.
Pages like this
not linked directly; found by shared links- PersonFranck Morschhauser
Shares the tags clinician-scientist, lymphoma, haematology.
- PersonSascha Dietrich
Shares the tags clinician-scientist, lymphoma, haematology.
- PersonAndrés J. M. Ferreri
Shares Primary CNS lymphoma and the tag lymphoma.
- PersonChris Hillis
Shares the tags clinician-scientist, haematology.
- PersonJoaquín Martínez-López
Shares the tags clinician-scientist, haematology.
- PersonLim Soon Thye
Shares the tags clinician-scientist, lymphoma.
- PersonNorbert Vey
Shares the tags clinician-scientist, haematology.
- PersonPeter Johnson
Shares the tags clinician-scientist, lymphoma.